International Psoriasis Council

Advancing Knowledge. Improving Care.

Filter Gallery Category: Guttate psoriasis

45-year-old patient with a history of untreated or inadequately managed psoriasis, with no significant improvement from topical treatments (e.g., corticosteroids or vitamin D analogs). Systemic therapies or biologics had not been administered. Relevant Clinical Information: The plaques presented with thick, grayish scaling and post-inflammatory hyperpigmentation on skin type V. The condition affected high-impact areas such as the scalp, palms, and soles, leading to functional impairment and reduced quality of life.

1AE – Phenotypes

45-year-old patient with a history of untreated or inadequately managed psoriasis, with no significant improvement from topical treatments (e.g., corticosteroids

Read More »
An 18-year-old male with guttate psoriasis presented with small purple and less pink plaques with some scaling over the extensor arms and trunk.

PC62

An 18-year-old male with guttate psoriasis presented with small purple and less pink plaques with some scaling over the extensor

Read More »

PC57

47-year-old male patient with guttate psoriasis. Presented with small purple plaques with slight scaling on the trunk.

<div class="addtoany_share_save_container addtoany_content
Read More »

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026